propranolol has been researched along with timolol in 278 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 158 (56.83) | 18.7374 |
1990's | 19 (6.83) | 18.2507 |
2000's | 36 (12.95) | 29.6817 |
2010's | 46 (16.55) | 24.3611 |
2020's | 19 (6.83) | 2.80 |
Authors | Studies |
---|---|
Baldwin, JJ; Engelhardt, EL; Hirschmann, R; Lumma, WC; Lundell, GF; Ponticello, GS; Raab, AW; Scriabine, A; Sweet, CS | 1 |
Herbette, LG; Mason, RP; Rhodes, DG | 1 |
Baldwin, JJ; Christy, ME; Denny, GH; Freedman, MB; Gross, DM; Habecker, CN; Lyle, PA; Ponticello, GS; Sweet, CS; Varga, SL | 1 |
Bodor, N; ElKoussi, A; Kano, M; Nakamura, T | 1 |
Alexander, J; Cargill, R; Michelson, SR; Schwam, H | 1 |
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Atkinson, JG; Baldwin, JJ; Engelhardt, EL; Hirschmann, R; Ponticello, GS; Scriabine, A; Sweet, CS; Wasson, BK | 1 |
Baldwin, JJ; Engelhardt, EL; Hirschmann, R; Ponticello, GS; Scriabine, A; Sweet, CS | 1 |
Baldwin, JJ; Denny, GH; Freedman, MB; Gross, DM; Hirschmann, R; Ponticello, GS; Sweet, CS | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Hwang, KK; Mandagere, AK; Thompson, TN | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Baker, JG | 1 |
Caron, G; Ermondi, G | 1 |
Chandrasena, G; Gavai, AV; Nayeem, A; Santone, K; Vaz, RJ | 1 |
Duke, BJ; Jackman, GP; Louis, SN; Louis, WJ; Machida, CA; Nero, TL; Rezmann-Vitti, LA | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Bard, B; Carrupt, PA; Martel, S | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Andring, JT; Bua, S; Carta, F; Ceruso, M; Filippi, L; Gratteri, P; Lanzi, C; Lomelino, CL; Masini, E; Matucci, R; McKenna, R; Nocentini, A; Pecori, R; Selleri, S; Sgambellone, S; Supuran, CT | 1 |
Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
Cohn, JR; Lefer, AM; Osman, GH | 1 |
Akerman, KE; Järvisalo, JO | 1 |
Mackie, IA; Pescod, JM; Seal, DV | 1 |
Folkers, K; Kishi, T; Watanabe, T | 1 |
Frohlich, ED; Pfeffer, JM; Pfeffer, MA; Weiss, AK | 1 |
Meier, J | 1 |
Le Douarec, JC; Plazonnet, B; Sears, ML; Silverstone, D; Stone, CA; Vareilles, P | 1 |
Dickerson, DD; Fulmor, IE; Goldberg, ME; Lee, RJ | 1 |
Katz, IM | 1 |
Lund-Johansen, P | 1 |
Wilcox, RG | 1 |
Bühler, FR; Burkart, F; Marbet, G; Patel, U | 1 |
Kiechel, JR; Meier, J | 1 |
Ishizaki, T; Tawara, K | 1 |
Bellucci, R; Bonomi, L; Massa, F; Noya, E; Perfetti, S | 2 |
Anderton, RC; Frith, PA; Hargreave, FE; Kumana, CR; Newhouse, MT; Ruffin, RE | 1 |
Eliasson, K; Lins, LE; Sundqvist, K | 1 |
Brown, B; Buckley, M; Darragh, A; Fitzgerald, D; Foley, JE; O'Kelly, D; Tormey, W; Vukovich, RA; Willard, DA | 1 |
Boger, WP | 1 |
Drummer, O; Jarrott, B; Louis, WJ; McNeil, JJ; Rand, MJ | 1 |
Nencini, P | 1 |
Lederballe Pedersen, O; Mikkelsen, E | 1 |
Neufeld, AH; Page, ED | 1 |
Julius, S; Kiowski, W; Simon, G | 2 |
Cheymol, G; Heckle, J; Jaillon, P; Weissenburger, J | 2 |
Frohlich, ED; Nishiyama, A; Nishiyama, K; Pfeffer, MA | 1 |
Riley, RL; Scriabine, A; Watson, LS | 1 |
Fujii, T | 1 |
Bousser, MG; Massiou, H | 1 |
Leon, M; McGaugh, JL; Sullivan, RM | 1 |
Dumasia, MC; Houghton, E | 1 |
Andries, LJ; Boels, PJ; Brutsaert, DL; De Laey, JJ; Hoste, AM | 1 |
Bhandare, P; Dhume, V; Diniz-D'Souza, R; Mainker, A | 1 |
Akritopoulos, P; Petounis, AD | 1 |
From, RP; Mehta, MP; Pathak, D | 1 |
Rajvanshi, P; Rizvi, SN | 1 |
Nathanson, JA | 1 |
Chiou, GC; Liu, HK; McLaughlin, MA; Watanabe, K | 1 |
Fletcher, GF | 1 |
Lennard, MS | 1 |
Andermann, G; Bouzoubaa, M; Erhart, M; Himber, J; Leclerc, G | 1 |
Smith, RL | 1 |
de Groot, G; de Wildt, D; Langemeijer, J; Sangster, B | 3 |
Fishbein, L; Jackson, CD | 1 |
Kjekshus, JK | 1 |
Halawa, B; Mazurek, W | 1 |
Lennard, MS; Silas, JH; Tucker, GT; Woods, HF | 1 |
Alkondon, M; Ray, A; Sen, P | 2 |
Maddox, YT; Mostaghim, R; Ramwell, PW | 1 |
Tfelt-Hansen, P | 1 |
Keshmirian, J; Nogrady, T | 1 |
Proegler, M; Schneider, H | 1 |
Gerber, U; Niemeyer, G; Uji, Y | 1 |
Kato, T; Nagamine, F; Nakasone, J; Noguchi, K; Sakanashi, M | 1 |
Ageel, AM; al-Meshal, IA; el-Feraly, FS; Islam, MW; Tariq, M | 1 |
Besser, GM; Grossman, A; Holly, JM; Rees, LH; Tsagarakis, S | 1 |
Bromberger-Barnea, B; Menkes, HA; Spannhake, EW; Weinmann, GG | 1 |
Alkondon, M; Khanna, N; Ray, A; Sen, P | 1 |
Aula, P; Huupponen, R; Kaila, T; Salminen, L | 1 |
Akbar, FA; Cranfield, FR; Markanday, S; Shelton, JR; Walters, EG | 1 |
de Groot, G; de Wildt, DJ; Langemeijer, JJ; Sangster, B | 1 |
Kralios, AC; Nanas, JN | 1 |
Draper, AJ; Kendall, HE; Redfern, PH | 1 |
Seal, DV | 1 |
DeLoach, G; Satumtira, N; Yorio, T | 1 |
Herbette, L; Katz, AM; Messineo, FC; Napolitano, CA | 1 |
Parker, VE; Vetrovec, GW | 1 |
Hayashi, M; Takase, M | 1 |
Vidt, DG | 1 |
Hopkins, WF; Johnston, D | 1 |
Clark, BG; Vestal, RE | 1 |
Potter, DE; Rowland, JM | 1 |
Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
Innemee, HC; Ros, FE; van Zwieten, PA | 1 |
Barr, RE; LeGrand, RD; Walkenbach, RJ | 1 |
Ohrström, A; Pandolfi, M | 1 |
Frishman, WH; Koch-Weser, J | 1 |
Borer, JS; Moses, JW | 1 |
Hampton, JR | 1 |
Le Douarec, JC; Lotti, VJ; Schmitt, C | 1 |
Ohrström, A | 1 |
Hjalmarson, A | 1 |
Gorlin, R; Moser, M | 1 |
Patel, L; Turner, P; Weerasuriya, K | 1 |
Iskandrian, AS; Kotler, MN; Segal, BL | 1 |
Moss, AJ | 1 |
Ciracì, G; Giummarra, C; Reibaldi, A | 1 |
Amery, A; Bulpitt, C; Cattaert, A; Fagard, R; Staessen, J; Vanhees, L | 1 |
Cerino, D; Kling, P; Lotti, VJ | 1 |
Julian, DG | 1 |
Bolte, HD | 1 |
Gettes, LS; Griggs, TR; Wagner, GS | 1 |
Honda, Y; Matsuda, H; Matsumura, M; Yoshimura, N | 1 |
Pratt, CM; Roberts, R | 1 |
Ribeiro, LG | 1 |
Ermakova, VN | 1 |
Gram, LF; Pedersen, OL | 1 |
Delius, W | 1 |
Kättström, O; Ohrström, A | 1 |
Weisswange, A | 1 |
Goldstein, S | 1 |
Friedewald, WT; Frishman, WH; Furberg, CD | 2 |
Teräväinen, H | 1 |
Jackson, EA; Sullman, SA | 1 |
Ask, JA; Stene-Larsen, G | 1 |
Ferguson, RK; Rotmensch, HH; Vlasses, PH | 1 |
Peele, ME; Shulkin, BL; Utiger, RD | 1 |
Turner, P | 1 |
Tomov, I | 1 |
McGoon, MD; Vlietstra, RE | 1 |
Abed, J; Donaldson, R; Nashat, F; Taggart, P | 1 |
Buja, LM; Willerson, JT | 1 |
Rose, G | 1 |
Baer, JE; Clineschmidt, BV; deLuna, FA; Duncan, AE; Tocco, DJ | 1 |
Clusin, WT; Gillis, AM | 1 |
Bromberg, BB; Gregory, DS; Sears, ML | 1 |
Dunwiddie, TV; Hoffer, BJ; Mueller, AL | 1 |
Clark, B; Trope, GE | 1 |
MacLeod, KM; McNeill, JH; Rodgers, RL; Siegl, PK | 1 |
Grignolo, A; Koepke, JP; Light, KC; Obrist, PA | 1 |
Remien, J | 1 |
Blondeau, P; Côté, M; Tétrault, L | 1 |
Khan, AH | 1 |
Hakkarainen, H; Kangasneimi, P; Olesen, J; Standnes, B; Tfelt-Hansen, P | 1 |
Kättström, O; Mortensen, J; Ohrström, A; Polland, W; Stenström, B | 1 |
Maroko, PR; Ribeiro, LG; Vik-Mo, H | 1 |
Bradley, L; Doggrell, SA | 1 |
Beylot, M; Borson, F; Cohen, R; Mornex, R; Riou, JP; Sautot, G | 1 |
Cannon, PJ; Escala, E; Feder, JL; Johnson, LL; Johnson, YE; Kalischer, AL; Stone, J | 1 |
Beylot, M; Borson, F; David, L; Mornex, R; Riou, JP; Sautot, G | 1 |
Bigger, JT; Gang, ES; Uhl, EW | 1 |
Crutcher, EC; Quinn, PJ | 1 |
Standnes, B | 1 |
Herbette, L; Katz, AM; Sturtevant, JM | 1 |
Gifford, R; Khairallah, P; Magnusson, M; Novick, A; Palleschi, J; Pechan, W; Stowe, N; Straffon, R | 1 |
Erikssen, J; Kjekshus, J; Thaulow, E | 1 |
Benatar, SR; Opie, LH | 1 |
Davies, RO; Firor, WB; Holmes, GI; Huber, PB; Johnson, GE; Tsianco, MC; Wilson, TW | 1 |
Miichi, H; Nagataki, S | 1 |
Cummins, P; Evemy, KL; Littler, WA | 1 |
Borba, P; Didier, M; França, P; Santos, A; Tenório, J | 1 |
Chew, C; Collett, J; Singh, BN; Whitlock, RM; Williams, FM | 1 |
Forfang, K; Gullestad, L | 1 |
Osterziel, KJ | 1 |
Chen, GF; Lu, YQ; Yang, ZC | 1 |
Bergsmark, J; Gadeholt, G | 1 |
Chirtel, SJ; Field, RB; Redman, RS | 1 |
Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
Hirvonen, J; Kontturi, K; Murtomäki, L | 1 |
Anderson, GM; Clark, JP; Gurwitz, JH; Lau, P; Rochon, PA; Shear, NH; Tu, JV | 1 |
Melena, J; Osborne, NN; Wood, JP | 1 |
Akerman, S; Järvinen, K; Karhu, M; Paronen, P; Savolainen, J; Svarfvar, B; Tarvainen, T | 1 |
Järvinen, K; Paronen, P; Sääskilahti, M; Svarfvar, B; Tarvainen, T; Urtii, A | 1 |
Chidlow, G; Melena, J; Osborne, NN | 1 |
Fadda, A; Ferrari, AU; Marano, G; Palazzesi, S; Vergari, A | 1 |
Chan, HK; Clark, BJ; Coleman, MW; Grosse, SC; Jouyban, A; Kenndler, E | 1 |
Maeda, A; Minami, M; Nakagawa, T; Satoh, M; Watanabe, T; Yamamoto, R | 1 |
Abou-Sekkina, MM; El-Ries, MA; Hassan, SS; Wassel, A | 1 |
Banga, AK; Betageri, GV; Chaturvedula, A; Conjeevaram, R; Sunkara, G | 1 |
Lu, WY; Wei, G; Zheng, JM | 1 |
Asadpour-Zeynali, K; Jouyban, A; Majidi, MR | 1 |
Iwaki, M; Kawase, A; Komura, H | 1 |
Fonarow, GC | 1 |
Hitchcock, K; Saseen, J; Sontheimer, D | 1 |
Arstall, MA; Beltrame, JF; Horowitz, JD; Zeitz, CJ | 1 |
Boralli, VB; Danhof, M; de Lange, EC; Freijer, J; Krekels, EH; Slijkerman, P; van Steeg, TJ | 1 |
Quimbo, RM; Rupnow, MF; Wertz, DA; Yaldo, AZ | 1 |
Gurdal, H; Sam, P; Seymen, AA; Tuncay, E; Turan, B | 1 |
Arrigan, DW; Glennon, JD; Herzog, G; Sisk, GD | 1 |
Firnhaber, JM; Rickett, K | 1 |
Pisklak, DM; Wawer, I; Zielińska-Pisklak, MA | 1 |
Blatt, J; Buck, S; Burkhart, CN; Gold, S; Morrell, DS; Powell, C; Stavas, J; Zdanski, C | 1 |
Guo, S; Langer, P; Ni, N | 1 |
Devost, D; Goupil, E; Hébert, TE; Iorio-Morin, C; Laporte, SA; Pétrin, D; Wrzal, PK; Zingg, HH | 1 |
Mains, J; Tan, LE; Urquhart, A; Wilson, C | 1 |
Frieden, IJ; Tollefson, MM | 1 |
Chantasart, D; Hao, J; Li, SK | 1 |
Antaya, RJ; Craiglow, BG | 1 |
Chen, B; Justin, R | 1 |
Chang, TC; Estes, R | 1 |
Goelz, R; Poets, CF | 1 |
Fiorillo, L; Korownyk, C; Ross, D | 1 |
Cohen, ER; Landy, DC; Ovadia, SA; Thaller, SR; Yang, EY | 1 |
Bayart, CB; Brandling-Bennett, HA | 1 |
Cheng, C; Gong, H; Li, G; Li, YX; Wang, XK; Xu, DP | 1 |
Fruge, JH; Massengale, WT; Rouhana, HF | 1 |
Li, G; Sun, NN; Tong, S; Wang, XK; Xu, DP; Xue, L | 1 |
Chinnadurai, S; Fonnesbeck, C; Likis, FE; McPheeters, ML; Morad, A; Sathe, NA; Snyder, KM | 1 |
Ge, J; Yuan, W; Zhang, L; Zhao, H; Zheng, J | 1 |
Adams, D; Baselga, E; Drolet, B; Feigenbaum, D; Frieden, I; Garzon, MC; Holland, K; Horii, K; Lauren, C; Lucky, A; Mathes, E; McCuaig, C; Morel, KD; Newell, B; Nopper, A; Pope, E; Powell, J; Püttgen, K; Savva, Y; Siegel, D; Song, W | 1 |
Cheng, CE; Friedlander, SF | 1 |
Fan, XD; Huo, R; Jiang, CH; Lei, SR; Liu, SH; Qin, ZP; Wang, XK; Wang, XY; Yang, YW; Zhao, JH; Zheng, JW; Zhou, DK | 1 |
Elmazar, HF; Khairy, HA; Mandour, SS; Marey, HM | 1 |
Baumann-Durchschein, F; Bucsics, T; Datz, C; Dolak, W; Ferlitsch, A; Fickert, P; Finkenstedt, A; Graziadei, I; Hametner, S; Karnel, F; Krones, E; Maieron, A; Mandorfer, M; Peck-Radosavljevic, M; Püspök, A; Rainer, F; Reiberger, T; Schoder, M; Schöfl, R; Schwabl, P; Stadlbauer, V; Stauber, R; Tilg, H; Trauner, M; Zoller, H | 1 |
Li, Y; Zheng, L | 1 |
Hasanzadeh, M; Niaei, N; Shadjou, N | 1 |
Arevalo-Rodriguez, I; Baselga, E; Beltran, S; Giraldo, L; Novoa, M; Pardo-Hernandez, H; Shahbaz, A | 2 |
Hagström, M; Kidron, H; Rimpelä, AK; Urtti, A | 1 |
Banks, CE; Khairy, M; Khorshed, AA | 1 |
Huang, AH; Lie, E; Mannschreck, DB; Psoter, K; Puttgen, K | 1 |
Janmohamed, SR | 1 |
Dany, M | 1 |
Cavalli, R; Chelleri, C; Fossali, EF; Galeone, C; Gelmetti, C; Milani, GP; Monzani, NA | 1 |
Li, H; Lin, Z; Yu, Z; Zhang, B | 1 |
Duell, K; McNab, S | 1 |
Artzi, O; Bar-Ilan, E; Friedman, O; Koren, A; Mashiah, J; Zur, E | 1 |
Chen, JJ; Guo, XD; Hu, DL; Shu, Q; Wu, XJ; Xu, S; Xuan, XX; Yang, H; Zhang, H | 1 |
Al-Refaie, AAA; El-Taweel, AEI; Salem, KHA; Salem, RM | 1 |
Gutermuth, J; Janmohamed, SR; Saerens, J | 1 |
Alfano, R; Argenziano, G; Babino, G; Briatico, G; Fulgione, E; Gambardella, A; Giorgio, CMR; Licata, G | 1 |
Chen, YW; Hsu, CW; Huang, KY; Lin, CH; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC | 1 |
Dinarevic, SM; Kardasevic, M | 1 |
Rodríguez Bandera, AL; Sebaratnam, DF; Wargon, O; Wong, LF | 1 |
Colmant, C; Powell, J | 1 |
McLean, TW; Pahl, KS | 1 |
Alcalá, R; Azaña Defez, JM; Azon, A; Bauzá, A; Bernabeu Wittel, J; Campos-Domínguez, M; Colmenero, M; Del Boz, J; Domínguez-Cruz, J; Feito-Rodríguez, M; García-Doval, I; Garnacho-Saucedo, G; Giacaman, A; González-Enseyat, MA; Grau-Pérez, M; Hernández-Martin, Á; Martín-Santiago, A; Monserrat García, MT; Palencia Pérez, SI; Roé, E; Sánchez Moya, AI; Tercedor-Sánchez, J; Torrelo, A; Valdivielso-Ramos, M; Vera Casaño, Á; Vicente-Villa, MA | 1 |
Albarki, H; Rimmer, J | 1 |
Cai, B; Chen, X; Huang, H; Wang, B; Yu, J | 1 |
Achim, M; Filip, GA; Freiha, M; Gheban, BA; Moldovan, R | 1 |
Ojha, HR; Verma, N | 1 |
46 review(s) available for propranolol and timolol
Article | Year |
---|---|
Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.
Topics: Cell Membrane; Chemical Phenomena; Chemistry, Physical; Kinetics; Lipid Bilayers; Membrane Lipids; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Structure-Activity Relationship | 1991 |
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
Oxidation phenotype and the metabolism and action of beta-blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Drug Interactions; Ethanolamines; Humans; Hypertension; Kinetics; Metoprolol; Oxidation-Reduction; Phenotype; Propranolol; Timolol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Humans; Metoprolol; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Time Factors; Timolol | 1986 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Metoprolol; Migraine Disorders; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1981 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Norway; Oxprenolol; Practolol; Propranolol; Random Allocation; Timolol | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Practolol; Propranolol; Prospective Studies; Random Allocation; Timolol | 1982 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorders; Propranolol; Serotonin Antagonists; Timolol; Vasomotor System | 1982 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; Metoprolol; Migraine Disorders; Myocardial Infarction; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Placebos; Practolol; Propranolol; Random Allocation; Sotalol; Time Factors; Timolol | 1984 |
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Catecholamines; Clinical Trials as Topic; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Humans; Metoprolol; Myocardial Infarction; Myocardium; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Time Factors; Timolol | 1984 |
The role of beta-adrenergic receptor antagonists in the prevention of sudden cardiac death.
Topics: Action Potentials; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Cardiac Complexes, Premature; Coronary Disease; Drug Therapy, Combination; Humans; Metoprolol; Myocardial Infarction; Propranolol; Recurrence; Time Factors; Timolol | 1984 |
Beta-blockers for the post-myocardial infarction patient: current clinical evidence and practical considerations.
Topics: Adrenergic beta-Antagonists; Algorithms; Atenolol; Carbazoles; Carvedilol; Humans; Myocardial Infarction; Practice Guidelines as Topic; Propanolamines; Propranolol; Randomized Controlled Trials as Topic; Secondary Prevention; Timolol | 2006 |
Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Family Practice; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Propranolol; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Timolol; Treatment Outcome | 2007 |
Is there still a role for treatment with beta-adrenoceptor antagonists in post-myocardial infarction patients with well-preserved left ventricular systolic function?
Topics: Adrenergic Antagonists; Angioplasty, Balloon, Coronary; Endothelium, Vascular; Humans; Metoprolol; Myocardial Infarction; Propranolol; Thrombolytic Therapy; Timolol; Ventricular Function, Left | 2008 |
Clinical inquiries. What are the best prophylactic drugs for migraine?
Topics: Adrenergic beta-Antagonists; Amitriptyline; Evidence-Based Medicine; Family Practice; Female; Fructose; Humans; Male; Migraine Disorders; Neuroprotective Agents; Pain Measurement; Practice Guidelines as Topic; Prognosis; Propranolol; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Severity of Illness Index; Timolol; Topiramate; Treatment Outcome | 2009 |
Current concepts in the management of periocular infantile (capillary) hemangioma.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Propranolol; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome | 2011 |
Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Aminoquinolines; Hemangioma; Humans; Imiquimod; Infant; Off-Label Use; Propranolol; Skin Neoplasms; Timolol | 2013 |
Incidence and treatment of infantile haemangioma in preterm infants.
Topics: Adrenergic beta-Antagonists; Cryotherapy; Hemangioma; Humans; Incidence; Infant, Premature; Infant, Premature, Diseases; Propranolol; Timolol; Treatment Outcome | 2015 |
Novel treatment for infantile hemangiomas.
Topics: Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Infant, Newborn; Propranolol; Timolol | 2014 |
Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Injections, Intralesional; Models, Statistical; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2015 |
Beta-blockers for childhood vascular tumors.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Child, Preschool; Facial Neoplasms; Humans; Infant; Neoplastic Syndromes, Hereditary; Neurocutaneous Syndromes; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome; Vascular Neoplasms | 2015 |
Beta blocker treatment for infantile hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2015 |
Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Glucocorticoids; Hemangioma; Humans; Infant; Infant, Newborn; Propranolol; Timolol | 2016 |
Infantile hemangiomas, complications and treatments.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Airway Obstruction; Drug Therapy, Combination; Esthetics; Facial Neoplasms; Hemangioma; Humans; Infant; Laser Therapy; Propranolol; Skin Neoplasms; Skin Ulcer; Timolol | 2016 |
Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis.
Topics: Administration, Topical; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Hemangioma; Humans; Infant, Newborn; Infant, Newborn, Diseases; Placebo Effect; Propranolol; Timolol | 2018 |
Interventions for infantile haemangiomas of the skin.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents; Bleomycin; Child, Preschool; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Methylprednisolone; Photochemotherapy; Prednisolone; Propranolol; Radiotherapy; Randomized Controlled Trials as Topic; Remission Induction; Skin Neoplasms; Timolol | 2018 |
Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review and GRADE assessments.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; GRADE Approach; Hemangioma; Humans; Hypotension; Placebos; Propranolol; Randomized Controlled Trials as Topic; Skin Neoplasms; Timolol | 2019 |
Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Betaxolol; Clinical Trials as Topic; Granuloma, Pyogenic; Humans; Propranolol; Receptors, Adrenergic, beta; Recurrence; Skin; Skin Diseases; Timolol; Treatment Outcome | 2019 |
Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 Cases.
Topics: Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Observational Studies as Topic; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2020 |
The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.
Topics: Administration, Topical; Adrenergic beta-Antagonists; China; Drug-Related Side Effects and Adverse Reactions; Hemangioma, Capillary; Humans; Propranolol; Timolol | 2020 |
The efficacy and safety of treatments for infantile hemangiomas: a Bayesian network meta-analysis.
Topics: Bayes Theorem; Hemangioma, Capillary; Humans; Network Meta-Analysis; Propranolol; Timolol | 2020 |
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Celiprolol; Disease Progression; Female; Humans; Incidence; Infusions, Intravenous; Male; Practolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Sotalol; Status Asthmaticus; Timolol | 2021 |
Infantile hemangioma. Part 2: Management.
Topics: Adrenergic beta-Antagonists; COVID-19; Hemangioma, Capillary; Humans; Infant; Nevus; Pandemics; Propranolol; SARS-CoV-2; Skin Neoplasms; Timolol; Treatment Outcome | 2021 |
Medical Management of Infantile Hemangiomas: An Update.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2022 |
Infantile Hemangioma: A Current Review.
Topics: Adrenergic beta-Antagonists; Child; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2022 |
The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Topics: Epistaxis; Humans; Propranolol; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Telangiectasia, Hereditary Hemorrhagic; Timolol | 2022 |
Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Combined Modality Therapy; Hemangioma; Humans; Infant; Lasers; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2022 |
46 trial(s) available for propranolol and timolol
Article | Year |
---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Airway Resistance; Asthma; Double-Blind Method; Drug Interactions; Female; Forced Expiratory Volume; Histamine; Humans; Male; Metoprolol; Middle Aged; Organ Specificity; Propranolol; Pulse; Timolol | 1979 |
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Drug Evaluation; Heart Rate; Humans; Kinetics; Male; Middle Aged; Oxprenolol; Physical Exertion; Pindolol; Propanolamines; Propranolol; Time Factors; Timolol | 1979 |
Clinical pharmacology of adrenergic-blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Pindolol; Placebos; Propranolol; Pulse; Timolol | 1979 |
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Pressoreceptors; Propanolamines; Propranolol; Reflex; Time Factors; Timolol | 1977 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rate; Humans; Hypokalemia; Myocardial Infarction; Myocardium; Oxygen Consumption; Propranolol; Random Allocation; Timolol | 1986 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Humans; Metoprolol; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Time Factors; Timolol | 1986 |
Efficacy of beta-blockers in migraine. A critical review.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Migraine Disorders; Nadolol; Propranolol; Racemases and Epimerases; Timolol | 1986 |
A comparative study of Spiroprop and Moducren in the treatment of mild to moderate hypertension in general practice.
Topics: Adolescent; Amiloride; Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Propranolol; Spironolactone; Timolol | 1988 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Drug Interactions; Epinephrine; Female; Hemodynamics; Humans; Intraocular Pressure; Male; Propranolol; Pupil; Timolol | 1980 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Norway; Oxprenolol; Practolol; Propranolol; Random Allocation; Timolol | 1981 |
Adrenergic beta-receptor blockers, adrenalin and intraocular pressure.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Clinical Trials as Topic; Drug Combinations; Epinephrine; Female; Humans; Intraocular Pressure; Male; Middle Aged; Propranolol; Pupil; Random Allocation; Timolol | 1982 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Practolol; Propranolol; Prospective Studies; Random Allocation; Timolol | 1982 |
Forum: beta-adrenoreceptor blockade after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial Infarction; Propranolol; Recurrence; Timolol | 1982 |
beta-Blockers and myocardial infarction.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Diuretics; Humans; Hypertension; Metoprolol; Myocardial Infarction; Propranolol; Recurrence; Time Factors; Timolol | 1982 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorders; Propranolol; Serotonin Antagonists; Timolol; Vasomotor System | 1982 |
Postinfarction therapy with beta blockers: who should be treated?
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Heart; Humans; Metoprolol; Myocardial Infarction; Propranolol; Random Allocation; Timolol | 1982 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myocardial Infarction; Oxprenolol; Practolol; Propranolol; Recurrence; Sotalol; Timolol | 1982 |
Beta-adrenergic blocking agents after myocardial infarction: an undocumented need in patients at lowest risk.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Propranolol; Research Design; Risk; Time Factors; Timolol | 1983 |
Chronic beta blockade therapy in patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myocardial Infarction; Practolol; Propranolol; Timolol | 1983 |
[Use of adrenergic beta blockaders after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Propranolol; Timolol | 1983 |
[Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Humans; Metoprolol; Middle Aged; Myocardial Infarction; Oxygen Consumption; Placebos; Prognosis; Propranolol; Timolol | 1983 |
A combination of oral and topical beta-blockers with additive effects on intraocular pressure.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Propranolol; Random Allocation; Timolol | 1983 |
[Improved prognosis using beta blockers after myocardial infarct?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Oxprenolol; Prognosis; Propranolol; Sotalol; Timolol | 1984 |
The Beta-Blocker Heart Attack Trial in perspective.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Norway; Placebos; Propranolol; Recurrence; Sotalol; Timolol | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial Infarction; Propranolol; Recurrence; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Beta-blocking drugs in migraine.
Topics: Adrenergic beta-Antagonists; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pregnancy; Propranolol; Receptors, Adrenergic, beta; Serotonin Antagonists; Timolol | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Placebos; Practolol; Propranolol; Random Allocation; Sotalol; Time Factors; Timolol | 1984 |
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Catecholamines; Clinical Trials as Topic; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Humans; Metoprolol; Myocardial Infarction; Myocardium; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Time Factors; Timolol | 1984 |
Effect of timolol eye drops in subjects receiving systemic propranolol therapy.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Propranolol; Time Factors; Timolol | 1983 |
Beta-adrenoreceptor blocking agents. Their role in reducing chances of recurrent infarction and death.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propranolol; Recurrence; Sympatholytics; Timolol | 1983 |
Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Random Allocation; Timolol | 1984 |
Oral and topical adrenergic beta-receptor blockers in glaucoma treatment. A multicenter study.
Topics: Administration, Oral; Clinical Trials as Topic; Glaucoma; Glaucoma, Open-Angle; Hemodynamics; Humans; Ophthalmic Solutions; Pilocarpine; Propranolol; Random Allocation; Timolol | 1984 |
Reduction of increased levels of blood glycerol and ketone bodies by propranolol in human hyperthyroidism: role of the fall of the triiodothyronine level.
Topics: Adolescent; Adult; Fatty Acids, Nonesterified; Female; Glycerol; Humans; Hyperthyroidism; Ketone Bodies; Male; Middle Aged; Propranolol; Propylthiouracil; Pulse; Timolol; Triiodothyronine | 1984 |
Reduction by propranolol of urinary hydroxyproline excretion in human hyperthyroidism: a beta-receptor blockade effect or a membrane stabilizing mechanism?
Topics: Adult; Female; Humans; Hydroxyproline; Hyperthyroidism; Male; Middle Aged; Propranolol; Propylthiouracil; Thyroxine; Timolol; Triiodothyronine | 1984 |
The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos; Propanolamines; Propranolol; Timolol | 1982 |
Beta-blocker prophylaxis after myocardial infarction.
Topics: Aging; Clinical Trials as Topic; Double-Blind Method; Humans; Myocardial Infarction; Placebos; Propanolamines; Propranolol; Timolol | 1981 |
Effect of timolol on platelet aggregation in coronary heart disease.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Aggregation; Propanolamines; Propranolol; Timolol | 1981 |
Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade.
Topics: Administration, Oral; Adult; Biological Availability; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Kinetics; Male; Physical Exertion; Propanolamines; Propranolol; Timolol | 1982 |
Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
Topics: Administration, Oral; Administration, Topical; Antineoplastic Agents; Drug Therapy, Combination; Facial Neoplasms; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Male; Mouth Neoplasms; Propranolol; Prospective Studies; Safety; Skin Neoplasms; Timolol; Treatment Outcome; Ultrasonography; Visual Analog Scale | 2016 |
Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
Topics: Administration, Oral; Administration, Topical; Aftercare; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Propranolol; Retrospective Studies; Skin Neoplasms; Time Factors; Timolol | 2016 |
Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Drug Therapy, Combination; Eye Neoplasms; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Neoplasm Staging; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Propranolol; Retrospective Studies; Time Factors; Timolol; Treatment Outcome | 2018 |
195 other study(ies) available for propranolol and timolol
Article | Year |
---|---|
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Chemistry, Pharmaceutical; Dogs; Hypertension; Imidazoles; Rabbits; Rats; Structure-Activity Relationship; Vasodilator Agents | 1979 |
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2.
Topics: Adrenergic beta-Antagonists; Animals; Female; Guinea Pigs; Heart Rate; Hydrogen Bonding; Imidazoles; In Vitro Techniques; Receptors, Adrenergic, beta; Solubility; Structure-Activity Relationship | 1986 |
Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Heart Rate; Indicators and Reagents; Intraocular Pressure; Male; Propranolol; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Timolol | 1988 |
(Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.
Topics: Adrenergic beta-Antagonists; Amines; Carbamates; Cell Membrane Permeability; Pharmaceutical Preparations; Prodrugs | 1988 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Female; Heart Rate; Hypertension; Isoproterenol; Male; Pyridines; Rats; Regional Blood Flow; Structure-Activity Relationship; Vasodilator Agents | 1980 |
Approaches to vasodilating/beta-adrenergic blocking agents: examples of the dihydrolutidine type.
Topics: Adrenergic beta-Antagonists; Animals; Chemical Phenomena; Chemistry; Dogs; Female; Male; Nifedipine; Propanolamines; Vasodilator Agents | 1981 |
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class.
Topics: Adrenergic alpha-Agonists; Animals; Female; Guinea Pigs; Heart; Imidazoles; Indicators and Reagents; Isoproterenol; Magnetic Resonance Spectroscopy; Receptors, Adrenergic; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1983 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Dogs; Guinea Pigs; Humans; In Vitro Techniques; Inactivation, Metabolic; Liver; Microsomes, Liver; Models, Biological; Permeability; Pharmacokinetics; Rats; Species Specificity | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.
Topics: Animals; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Propanolamines; Quantitative Structure-Activity Relationship; Substrate Specificity | 2005 |
Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptor.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Models, Molecular; Mutagenesis, Site-Directed; Propanolamines; Rats; Receptors, Adrenergic, beta-1; Serine; Stereoisomerism; Transfection; Tyrosine | 2006 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy.
Topics: Adrenergic beta-Antagonists; Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Glaucoma; Humans; Intraocular Pressure; Male; Molecular Targeted Therapy; Rabbits; Receptors, Adrenergic, beta; Structure-Activity Relationship | 2018 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Once-daily treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Hypertension; Metoprolol; Pindolol; Propranolol; Timolol | 1976 |
Protective action of timolol in acute myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cats; Coronary Disease; Coronary Vessels; Female; Heart Rate; Lysosomes; Male; Membranes; Myocardium; Propanolamines; Propranolol; Timolol | 1977 |
Effect of propranolol and related drugs on transmembraneous pH differences in liposomes.
Topics: 4-Aminobenzoic Acid; Adrenergic beta-Antagonists; Binding Sites; Hydrogen-Ion Concentration; Ionophores; Liposomes; Membranes; Models, Biological; Phenolsulfonphthalein; Practolol; Procaine; Propranolol; Protons; Timolol | 1977 |
Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.
Topics: Adrenergic beta-Antagonists; Autoantibodies; Conjunctiva; Female; Humans; Lacrimal Apparatus; Male; Middle Aged; Muramidase; Practolol; Propanolamines; Propranolol; Tears; Timolol | 1977 |
Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q10-enzymes by clinically used adrenergic blockers of beta-receptors.
Topics: Adrenergic beta-Antagonists; Alprenolol; NADH, NADPH Oxidoreductases; Propranolol; Stereoisomerism; Timolol; Ubiquinone | 1977 |
Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiomegaly; Central Venous Pressure; Drinking Behavior; Female; Growth; Heart Rate; Hypertension; Pregnancy; Propranolol; Rats; Timolol | 1977 |
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Protein Binding; Sotalol; Timolol | 1977 |
Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
Topics: Adrenergic beta-Antagonists; Animals; Aqueous Humor; Chymotrypsin; Disease Models, Animal; Epinephrine; Intraocular Pressure; Isoproterenol; Male; Propanolamines; Propranolol; Rabbits; Sympathomimetics; Timolol; Water | 1977 |
Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arteriosclerosis; Atenolol; Blood Pressure; Depression, Chemical; Heart Rate; Isoproterenol; Male; Oxprenolol; Pindolol; Propanolamines; Propranolol; Rabbits; Timolol | 1978 |
beta-Blockers and the eye: an overview.
Topics: Adrenergic beta-Antagonists; Animals; Drug Synergism; Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Ocular Physiological Phenomena; Ophthalmic Solutions; Propranolol; Rabbits; Timolol | 1978 |
alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects.
Topics: Adrenergic beta-Antagonists; Alprenolol; Hemodynamics; Humans; Hypertension; Methyldopa; Metoprolol; Physical Exertion; Propranolol; Time Factors; Timolol | 1978 |
Renin-suppressive potency of various beta-adrenergic blocking agents at supine rest and during upright exercise.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Male; Oxprenolol; Physical Exertion; Pindolol; Posture; Practolol; Propranolol; Renin; Timolol | 1975 |
Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.
Topics: Adrenergic beta-Antagonists; Adult; Heart Rate; Humans; Male; Physical Exertion; Propanolamines; Propranolol; Time Factors; Timolol | 1978 |
Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Drug Tolerance; Ethanolamines; Intraocular Pressure; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rabbits; Sotalol; Timolol | 1979 |
Vasospastic phenomena in patients treated with beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Circulation; Cardiac Output; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propranolol; Raynaud Disease; Skin Temperature; Timolol | 1979 |
The treatment of glaucoma: role of beta-blocking agents.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Glaucoma; Humans; Intraocular Pressure; Propranolol; Timolol | 1979 |
The influence of calcium on the antilipolytic action of propranolol, timolol, labetalol, verapamil, procaine, and papaverine in rat adipocytes.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Animals; Calcium; In Vitro Techniques; Isoproterenol; Labetalol; Lipolysis; Male; Papaverine; Procaine; Propranolol; Rats; Timolol; Vasodilator Agents; Verapamil | 1979 |
Beta-blocker withdrawal syndrome.
Topics: Humans; Metoprolol; Nifedipine; Propanolamines; Propranolol; Pyridines; Substance Withdrawal Syndrome; Timolol | 1979 |
In vitro determination of the ability of drugs to bind to adrenergic receptors.
Topics: Alprenolol; Animals; Ciliary Body; Clonidine; Dihydroergotoxine; Dopamine; Epinephrine; In Vitro Techniques; Iris; Isoproterenol; Male; Phentolamine; Propranolol; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Timolol | 1977 |
Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.
Topics: Animals; Atrioventricular Node; Dogs; Female; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Neural Conduction; Propanolamines; Propranolol; Refractory Period, Electrophysiological; Timolol | 1979 |
Effect of systemic autonomic inhibition on the hemodynamic response to antihypertensive therapy with timolol.
Topics: Adult; Atropine; Autonomic Nervous System; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Phentolamine; Placebos; Propanolamines; Propranolol; Timolol; Vascular Resistance | 1979 |
[Sympathomimetic and sympatholytic drugs in the therapy of glaucoma (author's transl)].
Topics: Albuterol; Clonidine; Epinephrine; Glaucoma; Humans; Isoproterenol; Norepinephrine; Propranolol; Sympatholytics; Sympathomimetics; Timolol | 1977 |
Comparative dromotropic activity of timolol and propranolol in anesthetized dogs.
Topics: Animals; Atropine; Dogs; Electric Stimulation; Electrocardiography; Female; Heart Conduction System; Heart Rate; Isoproterenol; Male; Neural Conduction; Propanolamines; Propranolol; Time Factors; Timolol | 1978 |
Systemic and regional flow distribution in normotensive and spontaneously hypertensive young rats subjected to lifetime beta-adrenergic receptor blockade.
Topics: Animals; Body Weight; Cardiac Output; Coronary Circulation; Drinking; Female; Heart; Hemodynamics; Hypertension; Maternal-Fetal Exchange; Microspheres; Organ Size; Pregnancy; Propanolamines; Propranolol; Rats; Regional Blood Flow; Timolol | 1978 |
Effect of timolol on hydralazine-induced increase in plasma renin activity in spontaneously hypertensive and normotensive rats.
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Hydralazine; Hypertension; Propanolamines; Propranolol; Rats; Renin; Species Specificity; Timolol | 1976 |
Mitigation of caffeine-induced fetopathy in mice by pretreatment with beta-adrenergic blocking agents.
Topics: Abnormalities, Drug-Induced; Animals; Caffeine; Female; Fetus; Mice; Mice, Inbred ICR; Pregnancy; Propanolamines; Propranolol; Time Factors; Timolol | 1976 |
Norepinephrine-induced plasticity and one-trial olfactory learning in neonatal rats.
Topics: Animals; Animals, Newborn; Brain; Conditioning, Psychological; Deoxyglucose; Female; Handling, Psychological; Isoproterenol; Learning; Male; Norepinephrine; Odorants; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Smell; Timolol | 1991 |
Screening and confirmatory analysis of beta-agonists, beta-antagonists and their metabolites in horse urine by capillary gas chromatography-mass spectrometry.
Topics: Administration, Oral; Animals; Clenbuterol; Doping in Sports; Gas Chromatography-Mass Spectrometry; Horses; Injections, Intravenous; Isoxsuprine; Metoprolol; Propranolol; Timolol | 1991 |
Effects of beta-antagonists on contraction of bovine retinal microarteries in vitro.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Capillaries; Cattle; Hydroxydopamines; In Vitro Techniques; Isometric Contraction; Lidocaine; Muscle, Smooth, Vascular; Oxidopamine; Propranolol; Retinal Artery; Serotonin; Timolol; Vasoconstriction; Verapamil | 1990 |
Protective effect of propranolol on ethanol-induced gastric lesions in mice.
Topics: Administration, Oral; Animals; Ethanol; Gastrointestinal Hemorrhage; Indomethacin; Injections, Intraperitoneal; Male; Mice; Premedication; Propranolol; Stomach Ulcer; Timolol | 1990 |
Influence of topical and systemic beta-blockers on tear production.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Butoxamine; Drug Administration Routes; Injections, Intramuscular; Lacrimal Apparatus; Male; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Rabbits; Time Factors; Timolol | 1989 |
Serum potassium concentrations following succinylcholine in patients undergoing beta-adrenoceptor blocking therapy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Heart Rate; Humans; Metoprolol; Middle Aged; Nadolol; Ophthalmic Solutions; Potassium; Propranolol; Succinylcholine; Time Factors; Timolol | 1989 |
Comparative evaluation of the antihypertensive effect of timolol and propranolol in patients with essential hypertension.
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Timolol | 1989 |
Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heart.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Adult; Aged; Animals; Ciliary Body; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Kinetics; Male; Methylation; Middle Aged; Myocardium; Propanolamines; Propranolol; Rabbits; Receptors, Adrenergic, beta; Timolol | 1985 |
Are beta-adrenergic mechanisms involved in ocular hypotensive actions of adrenergic drugs?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Aqueous Humor; Butoxamine; Cats; Dihydroalprenolol; Female; Intraocular Pressure; Male; Metoprolol; Propanolamines; Propranolol; Timolol | 1985 |
Exercise training during chronic beta blockade in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Coronary Artery Bypass; Female; Heart Rate; Humans; Male; Metoprolol; Myocardial Infarction; Nadolol; Physical Exertion; Propanolamines; Propranolol; Timolol | 1985 |
In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Anti-Bacterial Agents; Cattle; Cornea; In Vitro Techniques; Membrane Potentials; Propanolamines; Propranolol; Rabbits; Solubility; Timolol | 1985 |
Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance.
Topics: Adrenergic beta-Antagonists; Animals; Biological Availability; Blood Pressure; Debrisoquin; Ethanolamines; Glucuronates; Humans; Hydroxylation; Kinetics; Lipids; Metoprolol; Phenotype; Polymorphism, Genetic; Propranolol; Solubility; Structure-Activity Relationship; Timolol | 1985 |
Respiratory arrest as main determinant of toxicity due to overdose with different beta-blockers in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Blood Pressure; Electrocardiography; Hemodynamics; Male; Propranolol; Rats; Rats, Inbred Strains; Respiratory Insufficiency; Sotalol; Timolol | 1985 |
Calcium interferes with the cardiodepressive effects of beta-blocker overdose in isolated rat hearts.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Catecholamines; Coronary Circulation; Electric Stimulation; Heart; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Timolol | 1986 |
Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Debrisoquin; Genetic Variation; Humans; Hypertension; Isoquinolines; Kinetics; Male; Metoprolol; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Propranolol; Structure-Activity Relationship; Timolol | 1986 |
Tissue cholinesterase inhibition by propranolol and related drugs.
Topics: Animals; Brain; Cholinesterase Inhibitors; Female; Male; Myocardium; Parasympathetic Nervous System; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Timolol | 1986 |
Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Dinoprost; Dose-Response Relationship, Drug; Drug Synergism; Endothelium; Labetalol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Propanolamines; Propranolol; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Pyridines; Rats; Rats, Inbred Strains; Spiro Compounds; Timolol; Vasodilation | 1986 |
Rotifer neuropharmacology--III. Adrenergic drug effects on Brachionus plicatilis.
Topics: Albuterol; Animals; Cilia; Dose-Response Relationship, Drug; Isoproterenol; Movement; Norepinephrine; Phenylephrine; Propranolol; Receptors, Adrenergic; Rotifera; Timolol; Tolazoline | 1987 |
Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.
Topics: Adrenergic beta-Antagonists; Atenolol; Celiprolol; Female; Humans; In Vitro Techniques; Labetalol; Maternal-Fetal Exchange; Placenta; Pregnancy; Propanolamines; Propranolol; Timolol | 1988 |
[Effect of beta-blockers on retinal function in vitro].
Topics: Adrenergic beta-Antagonists; Animals; Cats; Dose-Response Relationship, Drug; Evoked Potentials, Visual; Optic Nerve; Perfusion; Propanolamines; Propranolol; Retina; Timolol | 1988 |
Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart; Heart Rate; In Vitro Techniques; Male; Metoprolol; Myocardial Contraction; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Timolol | 1988 |
Comparative study of cathinone and amphetamine on brown adipose thermogenesis.
Topics: Adipose Tissue, Brown; Alkaloids; Amphetamine; Animals; Body Temperature; Body Temperature Regulation; Dose-Response Relationship, Drug; Male; Propranolol; Rats; Rats, Inbred Strains; Timolol | 1989 |
Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
Topics: Acetylcholine; Animals; Calcium; Corticotropin-Releasing Hormone; Dioxanes; Hypothalamus; Idazoxan; In Vitro Techniques; Kinetics; Male; Moxisylyte; Norepinephrine; Potassium; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Timolol | 1988 |
Tonic beta-sympathetic activity in the lung periphery in anesthetized dogs.
Topics: Adrenalectomy; Aerosols; Airway Resistance; Animals; Atropine; Dogs; Isoproterenol; Lung; Male; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism; Sympathetic Nervous System; Timolol | 1985 |
Mechanisms involved in the modulation of acute inflammatory response in rats by propranolol.
Topics: Acute-Phase Reaction; Animals; Dose-Response Relationship, Drug; Inflammation; Male; Propranolol; Rats; Rats, Inbred Strains; Terbutaline; Timolol | 1987 |
Timolol binding to bovine ocular melanin in vitro.
Topics: Animals; Binding, Competitive; Cattle; Ethanol; Eye; Hydrogen-Ion Concentration; In Vitro Techniques; Iris; Kinetics; Melanins; Propranolol; Stereoisomerism; Timolol | 1988 |
Central origin of respiratory arrest in beta-blocker intoxication in rats.
Topics: Animals; Blood-Brain Barrier; Heart Rate; Injections, Intravenous; Injections, Intraventricular; Male; Propranolol; Rats; Respiration; Respiratory Insufficiency; Sotalol; Tidal Volume; Timolol | 1987 |
Relative effects of propranolol and timolol on ventricular fibrillation threshold and hemodynamics in the dog.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Electric Countershock; Electrocardiography; Female; Hemodynamics; Male; Propranolol; Stroke Volume; Timolol; Ventricular Fibrillation | 1986 |
The chronic effects of beta-adrenoreceptor antagonists on the efflux of tritiated noradrenaline from sympathetic nerves of the pithed rat.
Topics: Animals; Blood Pressure; Heart Rate; Male; Myocardium; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Timolol | 1986 |
The effect of ageing and disease on tear constituents.
Topics: Adult; Aged; Aging; Blepharitis; Ceruloplasmin; Eyelid Diseases; Humans; Immunoglobulin A; Immunoglobulin G; Keratoconjunctivitis; Labetalol; Lactoferrin; Middle Aged; Muramidase; Pemphigoid, Bullous; Practolol; Propranolol; Tears; Timolol; Xerophthalmia | 1985 |
Effects of antiglaucoma drugs on [32P]orthophosphate incorporation into phospholipids of cat iris and ciliary process.
Topics: Animals; Atenolol; Carbachol; Cats; Ciliary Body; Intraocular Pressure; Iris; Phosphates; Phospholipids; Pilocarpine; Propranolol; Timolol | 1985 |
Interaction of amphiphilic molecules with biological membranes. A model for nonspecific and specific drug effects with membranes.
Topics: Animals; Calcium; Calorimetry; Dimyristoylphosphatidylcholine; Ethanol; Lipid Bilayers; Models, Biological; Propranolol; Rabbits; Sarcoplasmic Reticulum; Timolol | 1985 |
Acute electrophysiologic, hemodynamic and left ventricular effects of nifedipine and beta-blocker interactions. Maintenance of global and regional left ventricular wall motion.
Topics: Administration, Oral; Angina Pectoris; Cardiac Catheterization; Cardiac Output; Drug Evaluation; Drug Synergism; Electrophysiology; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Nifedipine; Propranolol; Pulmonary Wedge Pressure; Stroke Volume; Timolol; Vascular Resistance | 1985 |
[A population study of the poor metabolizers of the debrisoquine type in Japan].
Topics: Administration, Oral; Asian People; Debrisoquin; Humans; Isoquinolines; Japan; Male; Propranolol; Timolol | 1985 |
Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus.
Topics: Adrenergic Fibers; Animals; Electric Stimulation; Evoked Potentials; Hippocampus; In Vitro Techniques; Isoproterenol; Male; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Synapses; Synaptic Transmission; Timolol | 1984 |
Adverse drug reactions in the elderly: case studies.
Topics: Acetazolamide; Aged; Anemia, Hemolytic; Bromocriptine; Captopril; Chlorpropamide; Cimetidine; Clonidine; Dienestrol; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydralazine; Lung Diseases; Male; Middle Aged; Nitrofurantoin; Pancreatitis; Papaverine; Peripheral Nervous System Diseases; Procainamide; Propranolol; Sulindac; Theophylline; Timolol | 1984 |
Adrenergic drugs and intraocular pressure: suppression of ocular hypertension induced by water loading.
Topics: Adrenergic beta-Antagonists; Animals; Butoxamine; Dobutamine; Ephedrine; Epinephrine; Intraocular Pressure; Isoproterenol; Male; Metoprolol; Propranolol; Pupil; Rabbits; Sympathomimetics; Terbutaline; Timolol; Water | 1980 |
Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Aqueous Humor; Atenolol; Carbon Radioisotopes; Ciliary Body; Cornea; Eye; Female; Iris; Male; Metoprolol; Nictitating Membrane; Propranolol; Rabbits; Timolol; Tritium | 1980 |
Characterization of adenylate cyclase activity in bovine and human corneal epithelium.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cattle; Cornea; Epithelium; Fluorides; Guanosine Triphosphate; Humans; Propranolol; Prostaglandins; Timolol | 1980 |
Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.
Topics: Administration, Topical; Adrenergic beta-Agonists; Alprenolol; Animals; Aqueous Humor; Chromatography, Gas; Oxprenolol; Practolol; Propranolol; Rabbits; Timolol | 1981 |
Beta-blockers after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Humans; Metoprolol; Myocardial Infarction; Propranolol; Timolol | 1982 |
Managing angina with beta blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Humans; Metoprolol; Nadolol; Nitrates; Propanolamines; Propranolol; Timolol | 1982 |
[The effect of antiglaucoma drugs on the depth of the anterior chamber (I)].
Topics: Adult; Anterior Chamber; Carbachol; Clonidine; Glaucoma; Humans; Middle Aged; Miotics; Moxisylyte; Pilocarpine; Propranolol; Quinuclidines; Timolol | 1982 |
High and low (Gpp(NH)p-sensitive) affinity sites for beta 2-adrenergic blockers as antagonists of isoproterenol in the field-stimulated rat vas deferens.
Topics: Adrenergic beta-Antagonists; Albuterol; Animals; Electric Stimulation; Guanosine Triphosphate; Guanylyl Imidodiphosphate; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Timolol; Vas Deferens | 1982 |
Secondary prevention after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Humans; Metoprolol; Myocardial Infarction; Prognosis; Propranolol; Timolol | 1982 |
[Beta receptor blockaders. Pharmacokinetics and therapeutic effects].
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Biological Availability; Guinea Pigs; Humans; Kinetics; Pindolol; Propranolol; Timolol | 1982 |
The retinal toxicity of befunolol and other adrenergic beta-blocking agents: inhibition of phagocytic activity of cultured retinal pigment epithelial cells.
Topics: Adrenergic beta-Antagonists; Animals; Cells, Cultured; Chick Embryo; Phagocytosis; Pigment Epithelium of Eye; Pilocarpine; Propanolamines; Propranolol; Timolol | 1983 |
[Effect of beta-adrenoblockers on prostaglandin-induced ocular hypertension in rabbits].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dinoprostone; Male; Ocular Hypertension; Oxprenolol; Propanolamines; Propranolol; Prostaglandins E; Rabbits; Timolol | 1983 |
[Beta blockade after myocardial infarction?].
Topics: Adrenergic beta-Antagonists; Humans; Myocardial Infarction; Propranolol; Timolol | 1983 |
Beta-blockers in isoproterenol-enhanced essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Isoproterenol; Metoprolol; Middle Aged; Propranolol; Timolol; Tremor | 1984 |
Functional alpha 1-adrenoceptors in the rat heart during beta-receptor blockade.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Dopamine; Epinephrine; Female; Heart; Methoxamine; Myocardial Contraction; Norepinephrine; Phenylephrine; Propranolol; Rats; Rats, Inbred Strains; Timolol | 1984 |
Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dithiothreitol; Liver; Male; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Timolol; Triiodothyronine | 1984 |
Beta-adrenergic blockers. Choosing among them.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
Class III action of beta-blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Ventricles; Male; Nadolol; Oxprenolol; Pindolol; Propanolamines; Propranolol; Sotalol; Timolol | 1984 |
Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dogs; Female; Heart Rate; Heart Ventricles; Male; Ouabain; Phenytoin; Propranolol; Tachycardia; Timolol; Vagotomy; Vagus Nerve | 1984 |
Beta-blockers after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Humans; Myocardial Infarction; Oxprenolol; Propranolol; Timolol | 1984 |
Uptake of the beta-adrenergic blocking agents propranolol and timolol by rodent brain: relationship to central pharmacological actions.
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Brain; Female; Mice; Propanolamines; Propranolol; Rats; Timolol | 1980 |
Beta-adrenergic receptors in ciliary processes of the rabbit.
Topics: Adenylyl Cyclases; Alprenolol; Animals; Cell Membrane; Ciliary Body; Epinephrine; Isoproterenol; Male; Phentolamine; Pindolol; Propranolol; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, beta; Timolol | 1980 |
Noradrenergic responses in rat hippocampus: evidence for medication by alpha and beta receptors in the in vitro slice.
Topics: Animals; Clonidine; Culture Techniques; Cyclic AMP; Evoked Potentials; Hippocampus; Isoproterenol; Male; Norepinephrine; Phentolamine; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Thionucleotides; Timolol | 1981 |
Beta adrenergic receptors in pigmented ciliary processes.
Topics: Albuterol; Animals; Cell Membrane; Ciliary Body; In Vitro Techniques; Male; Pigmentation; Pindolol; Practolol; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Sheep; Timolol | 1982 |
Inotropic responses, cyclic AMP, and time to peak tension in isolated cardiac preparations.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Electric Stimulation; Female; Gallopamil; Glucagon; Guinea Pigs; Histamine; Ion Channels; Isoproterenol; Male; Myocardial Contraction; Propranolol; Rats; Rats, Inbred Strains; Timolol | 1982 |
Central beta adrenoceptor mediation of the antinatriuretic response to behavioral stress in conscious dogs.
Topics: Animals; Behavior, Animal; Blood-Brain Barrier; Conditioning, Psychological; Consciousness; Dogs; Male; Natriuresis; Oxprenolol; Propranolol; Receptors, Adrenergic, beta; Stress, Physiological; Timolol | 1983 |
Beta-adrenoceptor recognition sites in living lymphocytes: a model for receptor properties in human disease?
Topics: Binding Sites; Humans; Iodocyanopindolol; Lymphocytes; Pindolol; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Timolol | 1984 |
Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Fatty Acids, Nonesterified; Female; Heart Rate; Male; Metoprolol; Myocardial Infarction; Myocardium; Oxygen Consumption; Propranolol; Timolol | 1984 |
Effects of the (+/-)-, (+)- and (-)-forms of propranolol, timolol and metoprolol on noradrenergic transmission in the rat isolated right ventricle.
Topics: Animals; Drug Interactions; Electric Stimulation; Heart Ventricles; In Vitro Techniques; Isomerism; Male; Metoprolol; Myocardial Contraction; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Stimulation, Chemical; Timolol; Tritium | 1984 |
Different toxicological profiles for various beta-blocking agents on cardiac function in isolated rat hearts.
Topics: Animals; Coronary Circulation; Depression, Chemical; Electric Stimulation; Heart Rate; Male; Myocardial Contraction; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Time Factors; Timolol | 1984 |
Effects of propranolol and timolol on left ventricular volumes during exercise in patients with coronary artery disease.
Topics: Adult; Aged; Cardiac Volume; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Propranolol; Radionuclide Imaging; Stroke Volume; Timolol | 1984 |
Effects of timolol and propranolol on inducible sustained ventricular tachyarrhythmias in dogs with subacute myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Dogs; Electrocardiography; Heart Ventricles; Myocardial Contraction; Myocardial Infarction; Propranolol; Timolol; Ventricular Fibrillation | 1984 |
The action of beta-adrenoceptor antagonists on rat heart mitochondrial function in vitro: a comparison of propranolol, timolol, and atenolol.
Topics: Animals; Atenolol; Depression, Chemical; Electron Transport; Male; Mitochondria, Heart; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Oxygen Consumption; Propranolol; Rats; Rats, Inbred Strains; Submitochondrial Particles; Timolol | 1984 |
Comparisons of the interaction of propranolol and timolol with model and biological membrane systems.
Topics: Animals; Biological Transport; Calcium; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; In Vitro Techniques; Lipid Bilayers; Membrane Lipids; Muscles; Neutrons; Phosphatidylcholines; Propanolamines; Propranolol; Rabbits; Sarcoplasmic Reticulum; Temperature; Timolol | 1983 |
Ocular hypotensive action of labetalol in rabbit and human eyes.
Topics: Animals; Dose-Response Relationship, Drug; Ethanolamines; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Labetalol; Male; Ophthalmic Solutions; Pilocarpine; Propranolol; Rabbits; Timolol | 1981 |
Pharmacologic protection against prolonged ischemia during harvesting and preservation of canine kidneys.
Topics: Animals; Dogs; Ischemia; Kidney; Kidney Transplantation; Organ Preservation; Propanolamines; Propranolol; Timolol; Tissue Preservation | 1981 |
Sudden death in asthmatics receiving beta-blockers.
Topics: Asthma; Death, Sudden; Humans; Propanolamines; Propranolol; Timolol | 1982 |
Effects of cholinergic drugs and adrenergic drugs on aqueous humor formation in the rabbit eye.
Topics: Albuterol; Animals; Aqueous Humor; Atropine; Epinephrine; Female; Intraocular Pressure; Isoproterenol; Male; Norepinephrine; Parasympathomimetics; Physostigmine; Pilocarpine; Propranolol; Rabbits; Sympathomimetics; Timolol | 1982 |
The effect of prolonged administration of propranolol and timolol on the growth and the heart of growing rabbits.
Topics: Animals; Body Weight; Eating; Growth; Heart; Heart Rate; Injections, Intraperitoneal; Injections, Subcutaneous; Propanolamines; Propranolol; Rabbits; Time Factors; Timolol | 1981 |
[Comparative study of the association of propranolol-chlorthalidone and the fixed combination of timolol-hydrochlorothiazide-amiloride in the treatment of arterial hypertension].
Topics: Amiloride; Antihypertensive Agents; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Propranolol; Timolol | 1981 |
Plasma timolol levels and systolic time intervals.
Topics: Adult; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Individuality; Male; Myocardial Contraction; Physical Exertion; Propanolamines; Propranolol; Systole; Tachycardia; Time Factors; Timolol | 1980 |
[Drug therapy of angina pectoris. Are the possibilities exploited well enough?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina, Unstable; Female; Humans; Isosorbide Dinitrate; Male; Metoprolol; Middle Aged; Propranolol; Retrospective Studies; Timolol | 1995 |
[Beta-receptor blockers after revascularization in coronary sclerosis].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Humans; Male; Metoprolol; Multicenter Studies as Topic; Myocardial Infarction; Propranolol; Recurrence; Time Factors; Timolol | 1995 |
Identification of beta-adrenoceptors in mouse myometrium by radioligand binding study.
Topics: Animals; Binding, Competitive; Cell Membrane; Dihydroalprenolol; Female; Mice; Myometrium; Norepinephrine; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta-2; Stereoisomerism; Timolol | 1994 |
[Nasal polyps and chronic sinusitis as a possible adverse effect of non-selective beta blockers].
Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Female; Humans; Male; Nasal Polyps; Propranolol; Recurrence; Rhinitis; Sinusitis; Timolol | 1994 |
Effect of substance P and receptor antagonists on secretion of lingual lipase and amylase from rat von Ebner's gland.
Topics: Amylases; Animals; Atropine; Biphenyl Compounds; Kinetics; Lipase; Male; Neurokinin-1 Receptor Antagonists; Propranolol; Rats; Rats, Sprague-Dawley; Salivary Glands; Substance P; Time Factors; Timolol; Tongue | 1997 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Experimental verification of the mechanistic model for transdermal transport including iontophoresis.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Biological Transport; Humans; Iontophoresis; Kinetics; Mathematical Computing; Models, Biological; Propranolol; Reproducibility of Results; Skin Absorption; Sotalol; Timolol | 1998 |
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Confidence Intervals; Databases as Topic; Diuretics; Drug Compounding; Evaluation Studies as Topic; Female; Humans; Hydrochlorothiazide; Logistic Models; Male; Metolazone; Metoprolol; Myocardial Infarction; Odds Ratio; Ontario; Propranolol; Retrospective Studies; Sex Factors; Sodium Chloride Symporter Inhibitors; Timolol | 1999 |
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium | 1999 |
Drug release from a porous ion-exchange membrane in vitro.
Topics: Acrylic Resins; Adsorption; Atenolol; Biocompatible Materials; Cations; Dexmedetomidine; Diazepam; Drug Delivery Systems; Hydrogen-Ion Concentration; Ion Transport; Kinetics; Membranes, Artificial; Polyvinyls; Propranolol; Sotalol; Surface Properties; Timolol | 1999 |
Drug release from cation exchange membrane in rabbit eye.
Topics: Acrylic Resins; Adsorption; Animals; Cations; Chromatography, High Pressure Liquid; Conjunctiva; Eye; Ion Exchange; Male; Membranes, Artificial; Osmolar Concentration; Polyvinyls; Propranolol; Rabbits; Timolol | 1999 |
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium | 2000 |
Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Disopyramide; Hypertrophy, Left Ventricular; Male; Propranolol; Rats; Rats, Inbred WKY; Stereoisomerism; Timolol | 2002 |
Calculation of electrophoretic mobility in mixed solvent buffers in capillary zone electrophoresis using a mixture response surface method.
Topics: Adrenergic beta-Antagonists; Electrophoresis, Capillary; Models, Chemical; Practolol; Propranolol; Solvents; Timolol | 2002 |
Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Avoidance Learning; Butoxamine; Conditioning, Operant; In Vitro Techniques; Male; Morphine; Naloxone; Narcotic Antagonists; Norepinephrine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Substance Withdrawal Syndrome; Timolol | 2003 |
Polymeric matrix membrane sensors for sensitive potentiometric determination of some beta-blockers in pharmaceutical preparations.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Indicators and Reagents; Ions; Metoprolol; Phosphates; Polyvinyl Chloride; Potentiometry; Propranolol; Sensitivity and Specificity; Timolol; Tungsten Compounds | 2003 |
Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Animals; Biological Transport; Chromatography, High Pressure Liquid; Drug Carriers; Injections, Intravenous; Iontophoresis; Irritants; Liposomes; Metoprolol; Oxprenolol; Propranolol; Rats; Skin; Skin Absorption; Sotalol; Stereoisomerism; Timolol | 2003 |
[Diffusion behaviors of drugs in thermosensitive in situ gels].
Topics: Albuterol; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; Gels; Poloxamer; Propranolol; Surface-Active Agents; Timolol | 2004 |
Modeling the electrophoretic mobility of beta-blockers in capillary electrophoresis using artificial neural networks.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrolytes; Electrophoresis, Capillary; Electrophoretic Mobility Shift Assay; Labetalol; Models, Chemical; Neural Networks, Computer; Pharmaceutical Preparations; Practolol; Predictive Value of Tests; Propranolol; Solvents; Technology, Pharmaceutical; Timolol | 2005 |
Application of substrate depletion assay for early prediction of nonlinear pharmacokinetics in drug discovery: assessment of nonlinearity of metoprolol, timolol, and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Area Under Curve; Blood Proteins; Drug Design; Female; Male; Metabolic Clearance Rate; Metoprolol; Microsomes, Liver; Nonlinear Dynamics; Predictive Value of Tests; Propranolol; Rats; Rats, Wistar; Substrate Specificity; Timolol | 2005 |
Influence of plasma protein binding on pharmacodynamics: Estimation of in vivo receptor affinities of beta blockers using a new mechanism-based PK-PD modelling approach.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Blood Proteins; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Male; Metoprolol; Models, Biological; Propranolol; Protein Binding; Rats; Rats, Inbred WKY; Receptors, Adrenergic, beta; Timolol | 2009 |
Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
Topics: Adult; Age Factors; Amitriptyline; Cohort Studies; Databases, Factual; Dose-Response Relationship, Drug; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Fructose; Humans; Kaplan-Meier Estimate; Male; Managed Care Programs; Medication Adherence; Middle Aged; Migraine Disorders; Proportional Hazards Models; Propranolol; Retrospective Studies; Sex Factors; Time Factors; Timolol; Topiramate; Valproic Acid | 2008 |
Effects of beta-adrenergic receptor blockers on cardiac function: a comparative study in male versus female rats.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Calcium; Female; Heart; Male; Propranolol; Rats; Rats, Wistar; Sex Characteristics; Timolol; Ventricular Function, Left | 2009 |
Assessment of ion transfer amperometry at liquid-liquid interfaces for detection in CE.
Topics: Benzenesulfonates; Electrochemistry; Electrolytes; Electrophoresis, Capillary; Equipment Design; Ions; Propranolol; Quaternary Ammonium Compounds; Sensitivity and Specificity; Tetraethylammonium; Timolol | 2009 |
1H and 13C NMR characteristics of β-blockers.
Topics: Acebutolol; Acids; Adrenergic beta-Antagonists; Alkalies; Alprenolol; Atenolol; Carbazoles; Carbon Isotopes; Carvedilol; Nuclear Magnetic Resonance, Biomolecular; Pindolol; Propanolamines; Propranolol; Protons; Timolol | 2011 |
β-blockers for infantile hemangiomas: a single-institution experience.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Drug Monitoring; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Laryngeal Neoplasms; Liver Neoplasms; Male; Propranolol; Retrospective Studies; Timolol | 2011 |
Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Allosteric Regulation; Atenolol; Cell Line; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Female; Humans; Immunoprecipitation; Isoproterenol; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myometrium; Oxytocin; Phosphorylation; Propranolol; Protein Binding; Protein Multimerization; Receptors, Adrenergic, beta-2; Receptors, Oxytocin; Recombinant Fusion Proteins; Signal Transduction; Timolol; Vasotocin | 2012 |
A pharmacokinetic study of a combination of beta adrenoreceptor antagonists - in the isolated perfused ovine eye.
Topics: Adrenergic beta-Antagonists; Animals; Anterior Eye Segment; Atenolol; Choroid; Intravitreal Injections; Posterior Eye Segment; Propranolol; Retina; Sheep; Timolol; Tissue Distribution | 2012 |
Drugs to prevent migraines are underused.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Fructose; Humans; Migraine Disorders; Preventive Health Services; Propranolol; Timolol; Treatment Outcome; United States; Valproic Acid | 2012 |
Early growth of infantile hemangiomas: what parents' photographs tell us.
Topics: Adrenal Cortex Hormones; Age Factors; Diseases in Twins; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lasers, Dye; Male; Nonlinear Dynamics; Photography; Propranolol; Referral and Consultation; Skin; Skin Neoplasms; Timolol; Treatment Outcome | 2012 |
Evaluation of skin permeation of β-blockers for topical drug delivery.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Epidermis; Humans; Middle Aged; Propranolol; Skin; Skin Absorption; Timolol; Young Adult | 2013 |
Characterisation and drug release performance of biodegradable chitosan-graphene oxide nanocomposites.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chitosan; Cisplatin; Drug Delivery Systems; Graphite; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Indomethacin; Nanocomposites; Oxides; Propranolol; Surface Properties; Timolol | 2014 |
Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
Topics: Adrenergic beta-Antagonists; Conjunctival Neoplasms; Female; Hemangioma; Humans; Infant; Propranolol; Timolol | 2014 |
Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
Topics: Adrenergic beta-Antagonists; Drug Combinations; Hemangioma; Humans; Propranolol; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome | 2015 |
Topical Timolol Maleate Treatment of Infantile Hemangiomas.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Cohort Studies; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Off-Label Use; Propranolol; Retrospective Studies; Skin Neoplasms; Timolol; Visual Analog Scale | 2016 |
[Chinese expert consensus on the use of topical timolol maleate treatment of infantile hemangiomas].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Asian People; Consensus; Expert Testimony; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2016 |
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).
Topics: Austria; Carbazoles; Carvedilol; Comorbidity; Early Medical Intervention; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Mass Screening; Propanolamines; Propranolol; Randomized Controlled Trials as Topic; Timolol | 2017 |
Molecular interaction of some cardiovascular drugs with human serum albumin at physiological-like conditions: A new approach.
Topics: Amiodarone; Atenolol; Captopril; Cardiovascular Agents; Humans; Hydrophobic and Hydrophilic Interactions; Propranolol; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Static Electricity; Timolol | 2018 |
Melanin targeting for intracellular drug delivery: Quantification of bound and free drug in retinal pigment epithelial cells.
Topics: Animals; Biological Transport; Cell Line; Chloroquine; Diclofenac; Epithelial Cells; Humans; Melanins; Methotrexate; Molecular Targeted Therapy; Propranolol; Retinal Pigment Epithelium; Swine; Timolol | 2018 |
Electrochemical determination of antihypertensive drugs by employing costless and portable unmodified screen-printed electrodes.
Topics: Amiloride; Amlodipine; Antihypertensive Agents; Drug Evaluation, Preclinical; Electrochemical Techniques; Electrodes; Humans; Printing; Propranolol; Timolol; Triamterene | 2019 |
Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Combined Modality Therapy; Drug Administration Schedule; Female; Hemangioma; Humans; Infant; Male; Propranolol; Retrospective Studies; Timolol; Treatment Outcome | 2019 |
Comment on "Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas".
Topics: Hemangioma; Hemangioma, Capillary; Humans; Propranolol; Timolol | 2019 |
Propranolol and topical timolol for infantile haemangiomas of the skin.
Topics: Hemangioma; Hemangioma, Capillary; Humans; Propranolol; Skin; Timolol | 2020 |
Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Drug Delivery Systems; Female; Hemangioma, Capillary; Humans; Hyperthermia, Induced; Infant; Male; Propranolol; Retrospective Studies; Skin Neoplasms; Timolol | 2020 |
Topical β-blockers for pyogenic granulomas: A promising option for younger patients.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Granuloma, Pyogenic; Humans; Propranolol; Recurrence; Timolol | 2021 |
An infant with localized vasoconstriction following topical propranolol exposure for infantile hemangioma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Propranolol; Timolol; Treatment Outcome; Vasoconstriction | 2021 |
Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma.
Topics: Adrenergic beta-Antagonists; Humans; Propranolol; Sarcoma, Kaposi; Skin Neoplasms; Timolol | 2021 |
Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Bosnia and Herzegovina; Female; Hemangioma; Humans; Infant; Propranolol; Sacrococcygeal Region; Timolol; Treatment Outcome; Vasodilator Agents | 2021 |
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain.
Topics: Child; Cross-Sectional Studies; Dermatologists; Hemangioma; Hemangioma, Capillary; Humans; Observer Variation; Pediatrics; Propranolol; Spain; Timolol | 2022 |
In Vivo Study of the Effects of Propranolol, Timolol, and Minoxidil on Burn Wound Healing in Wistar Rats.
Topics: Animals; Antioxidants; Burns; Female; Fibrosis; Inflammation; Minoxidil; Necrosis; Propranolol; Rats; Rats, Wistar; Silver Sulfadiazine; Timolol; Wound Healing | 2023 |
Early management of capillary haemangioma to prevent stimulus-deprivation amblyopia.
Topics: Amblyopia; Child; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Propranolol; Timolol | 2022 |